{"product_id":"clinical-pancreatology-for-practising-gastroenterologists-and-surgeons-isbn-9781119570073","title":"Clinical Pancreatology for Practising Gastroenterologists and Surgeons","description":"\u003cb\u003eClinical Pancreatology\u003c\/b\u003e \u003cp\u003eSince the book \u003ci\u003eClinical Pancreatology for Practising Gastroenterologists and Surgeons\u003c\/i\u003e was first published sixteen years ago, the knowledge and clinical management of pancreatic diseases have developed markedly. Thanks to the development of the translational research and the \u003ci\u003efrom bench to bedside\u003c\/i\u003e concept, much progress from the lab has been applied to clinical practice. In addition, several highly relevant clinical trials published over the last years have resulted in the update and optimisation of clinical guidelines.\u003c\/p\u003e\u003cp\u003eA new and validated classification of severity and complications of acute pancreatitis is firmly rooted in clinical practice and has been the basis for the development of minimally invasive approaches to pancreatic necrosis. The etiopathogenic knowledge of chronic pancreatitis and other pancreatopaties, like that associated with diabetes mellitus, has developed significantly. Especially important has been the development of the field of cystic pancreatic tumours, which has been reflected in the publication of several guidelines and consensus reports over the last few years. Most research efforts have focused on pancreatic cancer, which have led and will further lead to a significant increase in the therapeutic armamentarium against this devastating disease. Finally, many newly published studies have changed the concept, causes, clinical relevance, diagnosis and treatment of exocrine pancreatic insufficiency.\u003c\/p\u003e\u003cp\u003eThis new edition of \u003ci\u003eClinical Pancreatology for Practising Gastroenterologists and Surgeons\u003c\/i\u003e has enjoyed the collaboration of the world’s leading experts in each of the areas of clinical pancreatology with the aim of facilitating gastroenterologists, surgeons, oncologists, internists, nutritionists, diabetologists, paediatricians, radiologists, pathologists and other specialists in their decision making when facing patients with pancreatic diseases in their daily clinical practice. All in all, this book supplies an indispensable update of the relevant aspects of clinical pancreatology. \u003c\/p\u003e\u003cp\u003eContributors xxxiii\u003c\/p\u003e \u003cp\u003eForeword xlvi\u003c\/p\u003e \u003cp\u003ePreface xlvii\u003c\/p\u003e \u003cp\u003eDedication xlviii\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection I Acute Pancreatitis \u003c\/b\u003e\u003cb\u003e1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Acute Pancreatitis: An Overview 3\u003cbr\u003e\u003ci\u003eJodie A. Barkin and Jamie S. Barkin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 How to Deal with the Etiological Diagnosis of Acute Pancreatitis in Clinical Practice? 17\u003cbr\u003e\u003ci\u003eSoumya Jagannath and Pramod Kumar Garg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Definition of Complications and Severity of Acute Pancreatitis for Clinical Practice 25\u003cbr\u003e\u003ci\u003eDavid X. Jin, Peter A. Banks, and Julia McNabb-Baltar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Early Prediction of Severity in Acute Pancreatitis: What can be Done in Clinical Practice? 31\u003cbr\u003e\u003ci\u003ePeter J. Lee and Georgios I. Papachristou\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Role of CT Scan in Acute Pancreatitis: When is it Indicated and What Information can be Obtained? 40\u003cbr\u003e\u003ci\u003eElham Afghani, Mahya Faghih, and Vikesh K. Singh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Role of MRI in Acute Pancreatitis: When is it Indicated and What Information can be Obtained? 47\u003cbr\u003e\u003ci\u003eFatih Akisik\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Treatment of Acute Pancreatitis in The Emergency Room: What Should be Done During the First Hours of Disease? 53\u003cbr\u003e\u003ci\u003eThiruvengadam Muniraj and Santhi Swaroop Vege\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Acute Pancreatitis: A Practical Guideline for the Monitoring and Treatment of Systemic Complications 59\u003cbr\u003e\u003ci\u003eEnrique de Madaria and Felix Zubia-Olaskoaga\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Guidelines for the Treatment of Pain in Acute Pancreatitis 66\u003cbr\u003e\u003ci\u003eLászló Czakó\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Nutrition in the Acute Phase of Pancreatitis: Why, When, How and How Long? 72\u003cbr\u003e\u003ci\u003eAngela Pham and Chris E. Forsmark\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Oral Refeeding in Acute Pancreatitis: When and How Should it be Restarted? 78\u003cbr\u003e\u003ci\u003eJosé Lariño-Noia and Daniel de la Iglesia-García\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Pharmacological Therapy for Acute Pancreatitis: Any Light at the End of the Tunnel? 83\u003cbr\u003e\u003ci\u003eRajarshi Mukherjee, Muhammad Awais, Wenhao Cai, Wei Huang, Peter Szatmary, and Robert Sutton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Indication and Optimal Timing of ERCP in Acute Pancreatitis 95\u003cbr\u003e\u003ci\u003eTheodor Voiosu, Ivo Boškoski, and Guido Costamagna\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 How to Deal with Infected Pancreatic Necrosis? 100\u003cbr\u003e\u003ci\u003eJ. Enrique Domínguez-Muñoz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Minimally Invasive Surgical Necrosectomy in Clinical Practice: Indications, Technical Issues, and Optimal Timing 105\u003cbr\u003e\u003ci\u003ePatricia Sánchez-Velázquez, Fernando Burdío, and Ignasi Poves†\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Endoscopic Necrosectomy in Clinical Practice: Indications, Technical Issues and Optimal Timing 113\u003cbr\u003e\u003ci\u003eJodie A. Barkin and Andres Gelrud\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Management of Acute Pancreatic Pseudocyst: When to Observe, When and How to Drain? 120\u003cbr\u003e\u003ci\u003eMuhammad F. Dawwas and Kofi W. Oppong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 The Disconnected Main Pancreatic Duct Syndrome: How to Proceed in Clinical Practice? 126\u003cbr\u003e\u003ci\u003eMario Peláez-Luna, Andrea Soriano-Ríos, and Luis Uscanga-Dominguez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Vasculature Complications in Pancreatitis: How to Deal with Them? 132\u003cbr\u003e\u003ci\u003eDaniel G. McCall and Timothy B. Gardner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Acute Relapsing Pancreatitis: What can be Done to Prevent Relapses? 141\u003cbr\u003e\u003ci\u003eJorge D. Machicado and Dhiraj Yadav\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Diagnosis and Therapeutic Approach to Pancreatic Exocrine Insufficiency after Acute Pancreatitis 151\u003cbr\u003e\u003ci\u003eHester C. Timmerhuis, Christa J. Sperna Weiland, and Hjalmar C. van Santvoort\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Asymptomatic Chronic Elevation of Serum Pancreatic Enzymes: How to Deal with It? 158\u003cbr\u003e\u003ci\u003eGiuseppe Vanella, Paolo Giorgio Arcidiacono, and Gabriele Capurso\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection II Chronic Pancreatitis \u003c\/b\u003e\u003cb\u003e169\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e23 Definition and Etiology of Chronic Pancreatitis: What is Relevant for Clinical Practice? 171\u003cbr\u003e\u003ci\u003eDavid C. Whitcomb\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Epidemiology of Chronic Pancreatitis: An Infrequent Disease or an Infrequently Diagnosed Disease? 180\u003cbr\u003e\u003ci\u003ePhilippe Lévy and Vinciane Rebours\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Alcoholic Chronic Pancreatitis and the Impact of Alcohol and Smoking Cessation in Chronic Pancreatitis 185\u003cbr\u003e\u003ci\u003eJeremy S. Wilson, Romano C. Pirola, and Minoti V. Apte\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 What is Relevant on Genetics in Chronic Pancreatitis for Clinical Practice? What Genes and When to Evaluate Them? 193\u003cbr\u003e\u003ci\u003eJonas Rosendahl\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Pancreas Divisum and Other Potential Obstructive Causes of Chronic Pancreatitis: When and How to Treat Them? 198\u003cbr\u003e\u003ci\u003eMatthew J. DiMagno and Erik-Jan Wamsteker\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 What to do in Clinical Practice Before Defining a Chronic Pancreatitis as Idiopathic? A Practical Protocol 208\u003cbr\u003e\u003ci\u003eFelix Lämmerhirt, Frank Ulrich Weiss, and Markus M. Lerch\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Computed Tomography for the Diagnosis, Evaluation of Severity, and Detection of Complications of Chronic Pancreatitis in Clinical Practice 218\u003cbr\u003e\u003ci\u003eRoberto García-Figueiras, Sandra Baleato-González, and Gonzalo Tardáguila de la Fuente\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Role of MRI and MRCP in the Diagnosis, Evaluation of Severity, and Detection of Complications of Chronic Pancreatitis in Clinical Practice 227\u003cbr\u003e\u003ci\u003eJordan K. Swensson and Temel Tirkes\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31 Role of Endoscopic Ultrasound and Associated Methods (Elastography, Contrast Enhancement) in the Diagnosis, Evaluation of Severity, and Detection of Complications of Chronic Pancreatitis in Clinical Practice 233\u003cbr\u003e\u003ci\u003eJulio Iglesias-Garcia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Endoscopic Pancreatic Function Test for the Functional Diagnosis of Chronic Pancreatitis: Indications and Practical Protocol 243\u003cbr\u003e\u003ci\u003eLuis F. Lara and Darwin L. Conwell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Role of Pancreatic Function Tests for the Diagnosis of Chronic Pancreatitis: Which Tests and How Should they be Performed in Clinical Practice? 250\u003cbr\u003e\u003ci\u003eJ. Enrique Domínguez-Muñoz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Follow-up of Patients with Chronic Pancreatitis in Clinical Practice: How and What for? 255\u003cbr\u003e\u003ci\u003eAntonio Mendoza-Ladd, Luis F. Lara, and Darwin L. Conwell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Quality of Life in Chronic Pancreatitis 265\u003cbr\u003e\u003ci\u003eColin D. Johnson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Medical Treatment of Pain in Chronic Pancreatitis: Guidelines for Clinical Practice 273\u003cbr\u003e\u003ci\u003eAsbjørn Mohr Drewes, Louise Kuhlman, Trine Andresen, and Søren Schou Olesen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Endoscopic Treatment of Pain in Chronic Pancreatitis: Indications, Optimal Timing, and Technical Aspects 283\u003cbr\u003e\u003ci\u003ePauline M. C. Stassen, Pieter J. F. de Jonge, Jan-Werner Poley, Djuna L. Cahen, and Marco .J. Bruno\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38 Diagnosis and Management of Pancreatic Exocrine Insufficiency in Chronic Pancreatitis: A Practical Protocol 292\u003cbr\u003e\u003ci\u003eJ. Enrique Domínguez-Muñoz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e39 Surgical Treatment of Pain in Chronic Pancreatitis: Indications, Optimal Timing and Technical Approaches 301\u003cbr\u003e\u003ci\u003eBenjamin P.T. Loveday and John A. Windsor\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40 Management of Chronic Pancreatic Pseudocyst: When to Observe, When and How to Drain? 314\u003cbr\u003e\u003ci\u003eShyam Varadarajulu\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 Vascular Complications in Chronic Pancreatitis 322\u003cbr\u003e\u003ci\u003eAnil K. Agarwal, Raja Kalayarasan, and Amit Javed\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Surgical Therapy of Local Complications of Chronic Pancreatitis: Indications, Technical Approaches, and Optimal Timing 333\u003cbr\u003e\u003ci\u003eRicardo Arvizu Castillo, Elena Muñoz-Forner, and Luis Sabater\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e43 Endoscopic Treatment of Complications of Chronic Pancreatitis other than Pseudocyst 342\u003cbr\u003e\u003ci\u003eJahangeer Basha, Rupjyoti Talukdar, and D. Nageshwar Reddy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection III Autoimmune Pancreatitis \u003c\/b\u003e\u003cb\u003e347\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e44 Autoimmune Pancreatitis: Definition, Clinical Presentation, and Classification 349\u003cbr\u003e\u003ci\u003eMiroslav Vujasinovic and J. -Matthias Löhr\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e45 Diagnosis of Autoimmune Pancreatitis: A Protocol for Clinical Practice 356\u003cbr\u003e\u003ci\u003eNicolò de Pretis, Antonio Amodio, and Luca Frulloni\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e46 Treatment and Follow-up of Autoimmune Pancreatitis in Clinical Practice 360\u003cbr\u003e\u003ci\u003eSushil Kumar Garg and Suresh T. Chari\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection IV Cystic Fibrosis (CFTR)-associated Pancreatic Disease \u003c\/b\u003e\u003cb\u003e369\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e47 CFTR-associated Pancreatic Disease: Genotype–Phenotype Correlations and Impact of CFTR-modifying Therapy 371\u003cbr\u003e\u003ci\u003eAimee Joy Wiseman and Chee Y. Ooi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e48 Nutritional Therapy, Pancreatic Exocrine Insufficiency, and Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis: a Protocol for Clinical Practice 379\u003cbr\u003e\u003ci\u003eJefferson N. Brownell, Laura Padula, Elizabeth Reid, Virginia A. Stallings, and Asim Maqbool\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection V Pancreatic Cancer \u003c\/b\u003e\u003cb\u003e389\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e49 Epidemiological Impact of Pancreatic Cancer 391\u003cbr\u003e\u003ci\u003ePatrick Maisonneuve\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e50 Molecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts are Clinically Relevant? 404\u003cbr\u003e\u003ci\u003eIhsan Ekin Demir, Carmen Mota Reyes, Elke Demir, and Helmut Friess\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e51 New-onset Diabetes as a Harbinger of Pancreatic Cancer: is Early Diagnosis Possible? 409\u003cbr\u003e\u003ci\u003eDana K. Andersen, Suresh T. Chari, Eithne Costello, Tatjana Crnogorac-Jurcevic, Phil A. Hart, Anirban Maitra, and Stephen J. Pandol\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e52 Pancreatic Cancer Screening: Target Populations, Methods, and Protocols for Clinical Practice 418\u003cbr\u003e\u003ci\u003eChristopher Paiji, Anne Marie Lennon, and Elham Afghani\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e53 Clinical Usefulness of Biological Markers in Pancreatic Cancer 425\u003cbr\u003e\u003ci\u003eDavid Anz, Ignazio Piseddu, Marlies Köpke, Ujjwal M. Mahajan, and Julia Mayerle\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e54 Staging Classification and Stratification of Pancreatic Cancer for Clinical Practice 433\u003cbr\u003e\u003ci\u003eAkhil Chawla and Andrew J. Aguirre\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e55 Imaging Diagnosis and Staging of Pancreatic Cancer: Which Methods are Essential and What Information Should they Provide? 443\u003cbr\u003e\u003ci\u003eMegan H. Lee and Elliot K. Fishman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e56 The Role of Endoscopic Ultrasound and Associated Methods (Elastography, Contrast Enhancement) in the Diagnosis and Assessment of Resectability of Pancreatic Cancer 449\u003cbr\u003e\u003ci\u003eMarc. Giovannini\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e57 EUS-Guided FNA\/FNB for Pancreatic Solid Lesions: When is it Indicated and What is the Optimal Technical Approach? 460\u003cbr\u003e\u003ci\u003eMihai Rimbaș, Gianenrico Rizzatti, and Alberto Larghi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e58 Surgical Treatment of Resectable Pancreatic Cancer: What is the Optimal Strategy? 472\u003cbr\u003e\u003ci\u003eJan G. D’Haese, Bernhard W. Renz, and Jens Werner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e59 Complications After Pancreatic Surgery: How to Deal with Them? 477\u003cbr\u003e\u003ci\u003eTommaso Giuliani, Giovanni Marchegiani, Giuseppe Malleo, and Claudio Bassi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e60 Neoadjuvant Treatment of Pancreatic Cancer: When and How? 488\u003cbr\u003e\u003ci\u003eMarta Sandini, Thilo Hackert, Ulla Klaiber, Markus W. Büchler, and John P. Neoptolemos\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e61 Adjuvant Therapy in Pancreatic Cancer: Options, Safety, and Outcomes 501\u003cbr\u003e\u003ci\u003eJean-Luc Van Laethem\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e62 Management of Pain in Pancreatic Cancer: An Algorithm for Clinical Routine 506\u003cbr\u003e\u003ci\u003eJ. Enrique Domínguez-Muñoz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e63 EUS-guided Celiac Plexus Neurolysis for Pain in Pancreatic Cancer: When and How? 514\u003cbr\u003e\u003ci\u003eJonathan M. Wyse and Anand V. Sahai\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e64 The Role of Endoscopy in the Management of Unresectable Pancreatic Cancer 520\u003cbr\u003e\u003ci\u003eJaimin P. Amin, Ajaypal Singh, and Irving Waxman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e65 Chemotherapy for Nonresectable Pancreatic Cancer 530\u003cbr\u003e\u003ci\u003eRaquel Fuentes, Juan José Serrano, Mercedes Rodríguez, and Alfredo Carrato\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e66 Diagnosis and Management of Pancreatic Exocrine Insufficiency in Pancreatic Cancer 538\u003cbr\u003e\u003ci\u003eSarah Powell-Brett and Keith J. Roberts\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e67 Nutrition and Pancreatic Cancer 548\u003cbr\u003e\u003ci\u003eMary Phillips and Oonagh Griffin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e68 Present and Future of Local Therapies for Unresectable Pancreatic Cancer 555\u003cbr\u003e\u003ci\u003eSabrina Gloria Giulia Testoni, Gemma Rossi, Livia Archibugi, and Paolo Giorgio Arcidiacono\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e69 New Pharmacological Approaches for Pancreatic Cancer Therapy: A Light at the End of the Tunnel? 564\u003cbr\u003e\u003ci\u003eVineet K. Gupta, Sulagna Banerjee, and Ashok K. Saluja\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection VI Cystic Tumors of the Pancreas \u003c\/b\u003e\u003cb\u003e573\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e70 Histological Classification of Pancreatic Cystic Neoplasms 575\u003cbr\u003e\u003ci\u003eGiuseppe Zamboni and Anna Pesci\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e71 Role of Endoscopic Ultrasound and Endoscopic Ultrasound-associated Techniques in the Diagnosis and Differential Diagnosis of Pancreatic Cystic Tumors 584\u003cbr\u003e\u003ci\u003eMaría-Victoria Alvarez-Sánchez and Bertrand Napoléon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e72 The Role of Multidetector CT, MRI and MRCP in the Diagnosis and Differential Diagnosis of Pancreatic Cystic Neoplasms 593\u003cbr\u003e\u003ci\u003eMegan H. Lee and Elliot K. Fishman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e73 Intraductal Papillary Mucinous Neoplasm: When to Observe, When to Operate, and Optimal Surgical Approach 599\u003cbr\u003e\u003ci\u003eZhi Ven Fong and Carlos Fernandez-del Castillo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e74 Cystic Tumors Other than IPMN: When to Observe, When to Operate, and Optimal Surgical Approach 608\u003cbr\u003e\u003ci\u003eJohn W. Kunstman, and James J. Farrell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e75 Pancreatic Cystic Tumors: any Role for Local Therapies? 624\u003cbr\u003e\u003ci\u003eJulio Iglesias-Garcia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection VII Neuroendocrine and Other Tumors of the Pancreas \u003c\/b\u003e\u003cb\u003e631\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e76 Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors: How to Deal with them in Clinical Practice? 633\u003cbr\u003e\u003ci\u003eFrancesca Muffatti, Stefano Partelli, Valentina Andreasi, and Massimo Falconi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e77 Other less Frequent Pancreatic Tumors: What Should be Known about Clinical Features, Diagnosis and Treatment? 641\u003cbr\u003e\u003ci\u003eRossana Percario, Paolo Panaccio, Fabio F. di Mola, Pierluigi Di Sebastiano, and Tommaso Grottola\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection VIII Functional Alterations of the Pancreas in Other Clinical Situations \u003c\/b\u003e\u003cb\u003e651\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e78 Diagnosis and Therapy of Exocrine Pancreatic Insufficiency after Gastric and Pancreatic Surgery 653\u003cbr\u003e\u003ci\u003eRaffaele Pezzilli\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e79 Pancreatic Exocrine Insufficiency in Type 1 and Type 2 Diabetes Mellitus: Lessons from Pancreatologists to\u003cbr\u003eDiabetologists 662\u003cbr\u003e\u003ci\u003ePhilip D. Hardt                                   \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e80 Diabetes Mellitus Related to Diseases of the Exocrine Pancreas (Pancreatogenic Diabetes): Diagnosis and Treatment 668\u003cbr\u003e\u003ci\u003eDavid A. Bradley and Phil A. Hart\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 679\u003c\/p\u003e \u003cp\u003e\u003cb\u003eAbout the editor\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003eProf. \u003cb\u003eJ. Enrique Domínguez-Muñoz\u003c\/b\u003e graduated in medicine from the University of Alcalá de Henares in Madrid, and got his PhD at the same University in 1990. In 1998, he became Director of the Department of Gastroenterology and Hepatology at the University Hospital of Santiago de Compostela, Spain. He is also Professor of Medicine at the University of Santiago de Compostela and permanent member of the Royal Academy of Medicine of Galicia. He has published more than 300 papers in peer reviewed journals, and has edited 12 books. He has been elected President of the European Pancreatic Club for 2024.\u003c\/p\u003e  \u003cp\u003eSince the book \u003ci\u003eClinical Pancreatology for Practising Gastroenterologists and Surgeons\u003c\/i\u003e was first published sixteen years ago, the knowledge and clinical management of pancreatic diseases have developed markedly. Thanks to the development of the translational research and the \u003ci\u003efrom bench to bedside\u003c\/i\u003e concept, much progress from the lab has been applied to clinical practice. In addition, several highly relevant clinical trials published over the last years have resulted in the update and optimisation of clinical guidelines.\u003c\/p\u003e\u003cp\u003eA new and validated classification of severity and complications of acute pancreatitis is firmly rooted in clinical practice and has been the basis for the development of minimally invasive approaches to pancreatic necrosis. The etiopathogenic knowledge of chronic pancreatitis and other pancreatopaties, like that associated with diabetes mellitus, has developed significantly. Especially important has been the development of the field of cystic pancreatic tumours, which has been reflected in the publication of several guidelines and consensus reports over the last few years. Most research efforts have focused on pancreatic cancer, which have led and will further lead to a significant increase in the therapeutic armamentarium against this devastating disease. Finally, many newly published studies have changed the concept, causes, clinical relevance, diagnosis and treatment of exocrine pancreatic insufficiency.\u003c\/p\u003e\u003cp\u003eThis new edition of \u003ci\u003eClinical Pancreatology for Practising Gastroenterologists and Surgeons\u003c\/i\u003e has enjoyed the collaboration of the world’s leading experts in each of the areas of clinical pancreatology with the aim of facilitating gastroenterologists, surgeons, oncologists, internists, nutritionists, diabetologists, paediatricians, radiologists, pathologists and other specialists in their decision making when facing patients with pancreatic diseases in their daily clinical practice. All in all, this book supplies an indispensable update of the relevant aspects of clinical pancreatology.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47988934377701,"sku":"NP9781119570073","price":280.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119570073.jpg?v=1761782112","url":"https:\/\/k12savings.com\/es\/products\/clinical-pancreatology-for-practising-gastroenterologists-and-surgeons-isbn-9781119570073","provider":"K12savings","version":"1.0","type":"link"}